Cited by 433Cytokine Signaling Pathways and InteractionsTGF-β signaling in diseasesGrowth Hormone and Insulin-like Growth Factors

The DOI matches its Crossref record; 53 of the 59 references it cites were found in a registry or an index.

Persistent STAT3 Activation in Colon Cancer Is Associated with Enhanced Cell Proliferation and Tumor Growth

Open access

Corvinus, Florian M., Orth, Carina, Moriggl, Richard, Tsareva, Svetlana A., Wagner, Stefan, Pfitzner, Edith B., Baus, Daniela, Kaufman, Roland, Huber, Lukas A., Zatloukal, Kurt, Beug, Hartmut, Öhlschläger, Peter, Schütz, Alexander, Halbhuber, Karl-Jürgen, Friedrich, Karlheinz·2005·Neoplasia

DOI 10.1593/neo.04571PMC PMC1501283

Open this paper in CoChat — free account Open PDF

Abstract

Colorectal carcinoma (CRC) is a major cause of morbidity and mortality in Western countries. It has so far been molecularly defined mainly by alterations of the Wnt pathway. We show here for the first time that aberrant activities of the signal transducer and activator of transcription STAT3 actively contribute to this malignancy and, thus, are a potential therapeutic target for CRC. Constitutive STAT3 activity was found to be abundant in dedifferentiated cancer cells and infiltrating lymphocytes of CRC samples, but not in non-neoplastic colon epithelium. Cell lines derived from malignant colorectal tumors lost persistent STAT3 activity in culture. However, implantation of colon carcinoma cells into nude mice resulted in restoration of STAT3 activity, suggesting a role of an extracellular stimulus within the tumor microenvironment as a trigger for STAT activation. STAT3 activity in CRC cells triggered through interleukin-6 or through a constitutively active STAT3 mutant promoted cancer cell multiplication, whereas STAT3 inhibition through a dominant-negative variant impaired IL-6-driven proliferation. Blockade of STAT3 activation in CRC-derived xenograft tumors slowed down their development, arguing for a contribution of STAT3 to colorectal tumor growth.

Integrity signals

Registry

Crossref · 10.1593/neo.04571

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Stat3 as an Oncogene
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
STATs in oncogenesis
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., & Akira, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3801 · Cited by 1,323
Cytokine Signaling in 2002
O’Shea, J. J., Gadina, M., & Schreiber, R. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00701-8 · Cited by 1,137
Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
Ory, D., Neugeboren, B. I., & Mulligan, R. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11400 · Cited by 926
Stat proteins and oncogenesis
Bromberg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15617 · Cited by 863
What does Stat3 do?
Levy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 834
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro‐Cacho, C., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
What does Stat3 do?
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734

Show all 59 references

Sorted by citations

Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.005 · Cited by 645
Stem-Like Cells in Bone Sarcomas: Implications for Tumorigenesis
Gibbs, C. P., Kukekov, V. G., Reith, J. D., Tchigrinova, O., Suslov, O. N., Scott, E. W., Ghivizzani, S. C., Ignatova, T. N., & Steindler, D. A. (2005) · Neoplasia · doi:10.1593/neo.05394 · Cited by 492
Tumor exosomes inhibit differentiation of bone marrow dendritic cells
Yu, S., Liu, C., Su, K., Wang, J., Liu, Y., Zhang, L., Li, C., Cong, Y., Kimberly, R., Grizzle, W. E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6867 · Cited by 425
Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
Colussi, D., Brandi, G., Bazzoli, F., & Ricciardiello, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816365 · Cited by 429
Interleukin-6 - A Key Regulator of Colorectal Cancer Development
Waldner, M. J., Foersch, S., & Neurath, M. F. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4614 · Cited by 434
Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis
Kartikasari, A. E. R., Huertas, C. S., Mitchell, A., & Plebanski, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692142 · Cited by 343
“IL-6 via STAT-3 has been shown to promote tumor cell proliferation in many cancers, including oral squamous cell carcinoma via DNA hypomethylation (31), prostate cancer through androgen receptor activation (32), and colon cancer (33).”
Background
Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis
Li, Y., de Haar, C., Chen, M., Deuring, J., Gerrits, M. M., Smits, R., Xia, B., Kuipers, E. J., & van der Woude, C. J. (2010) · Gut · doi:10.1136/gut.2009.184176 · Cited by 339
Alternatively activated alveolar macrophages in pulmonary fibrosis—mediator production and intracellular signal transduction
Pechkovsky, D. V., Prasse, A., Kollert, F., Engel, K. M., Dentler, J., Luttmann, W., Friedrich, K., Müller–Quernheim, J., & Zissel, G. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.06.017 · Cited by 341
Self-citation
Smad4 signalling in T cells is required for suppression of gastrointestinal cancer
Kim, B., Li, C., Qiao, W., Mamura, M., Kasperczak, B., Anver, M. R., Wolfraim, L. A., Hong, S., Mushinski, E. B., Potter, M., et al. (2006) · Nature · doi:10.1038/nature04846 · Cited by 325
Cancer stem cells in colorectal cancer: a review
Munro, M. J., Wickremesekera, S. K., Peng, L., Tan, S. T., & Itinteang, T. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204739 · Cited by 315
STAT3 Is Necessary for Proliferation and Survival in Colon Cancer–Initiating Cells
Lin, L., Liu, A., Peng, Z., Lin, H.-J. L., Li, P., Li, C., & Lin, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4660 · Cited by 295
Highlighted STAT3 as a potential drug target for cancer therapy
Lee, H., Jeong, A. J., & Ye, S. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.7.152 · Cited by 301
STAT‐mediated EGFR signaling in cancer
Quesnelle, K. M., Boehm, A. L., & Grandis, J. R. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21475 · Cited by 300
Immunotherapy, Inflammation and Colorectal Cancer
Lichtenstern, C. R., Ngu, R. K., Shalapour, S., & Karin, M. (2020) · Cells · doi:10.3390/cells9030618 · Cited by 296
Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
Xiong, A., Yang, Z., Shen, Y., Zhou, J., & Shen, Q. (2014) · Cancers · doi:10.3390/cancers6020926 · Cited by 288
Regulation of translocator protein 18kDa (TSPO) expression in health and disease states☆
Batarseh, A. M., & Papadopoulos, V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.06.013 · Cited by 286
Targeting transcription factor STAT3 for cancer prevention and therapy
Chai, E. Z. P., Shanmugam, M. K., Arfuso, F., Dharmarajan, A., Wang, C., Kumar, A. P., Samy, R. P., Lim, L. H. K., Wang, L., Goh, B. C., et al. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.004 · Cited by 272
NF-κB pathways in the development and progression of colorectal cancer
Patel, M., Horgan, P. G., McMillan, D. C., & Edwards, J. (2018) · Translational research · doi:10.1016/j.trsl.2018.02.002 · Cited by 254
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies
Allegra, A., Innao, V., Russo, S., Gerace, D. G., Alonci, A., & Musolino, C. (2016) · Cancer Investigation · doi:10.1080/07357907.2016.1247166 · Cited by 244
Ups and downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling
Regis, G., Pensa, S., Boselli, D., Novelli, F., & Poli, V. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.06.004 · Cited by 241
Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy
Bhat, A. A., Nisar, S., Singh, M. K., Ashraf, B., Masoodi, T., Prasad, C. P., Sharma, A., Maacha, S., Karedath, T., Hashem, S., et al. (2022) · 癌症：英文版 · doi:10.1002/cac2.12295 · Cited by 251
Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer
Amin, M. N., Siddiqui, S. A., Ibrahim, M., Hakim, M. L., Ahammed, M. S., Kabir, A., & Sultana, F. (2020) · SAGE Open Medicine · doi:10.1177/2050312120965752 · Cited by 236
A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated Tumorigenesis
Deng, L., Zhou, J.-F., Sellers, R. S., Li, J.-F., Nguyen, A., Wang, Y., Orlofsky, A., Liu, Q., Hume, D. A., Pollard, J. W., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090622 · Cited by 232
The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives
Farha, A. K., Gan, R., Li, H., Wu, D., Atanasov, A. G., Gul, K., Zhang, J.-R., Yang, Q., & Corke, H. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1829541 · Cited by 233
miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation
Foshay, K. M., & Gallicano, G. I. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.11.016 · Cited by 226
Cytokine-Induced Modulation of Colorectal Cancer
Mager, L. F., Wasmer, M.-H., Rau, T. T., & Krebs, P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00096 · Cited by 223
Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T
Zhang, X., Guo, A., Yu, J., Possemato, A. P., Chen, Y., Zheng, W., Polakiewicz, R. D., Kinzler, K. W., Vogelstein, B., Velculescu, V. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611665104 · Cited by 214
Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Debnath, B., Xu, S., & Neamati, N. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300207s · Cited by 206
STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers
Morikawa, T., Baba, Y., Yamauchi, M., Kuchiba, A., Nosho, K., Shima, K., Tanaka, N., Huttenhower, C., Frank, D. A., Fuchs, C. S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2694 · Cited by 200
Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis
Lee, E., Fertig, E. J., Jin, K., Sukumar, S., Pandey, N. B., & Popel, A. S. (2014) · Nature Communications · doi:10.1038/ncomms5715 · Cited by 197
Ursolic acid, a potential anticancer compound for breast cancer therapy
Yin, R., Li, T., Tian, J., Xi, P., & Liu, R. H. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1203755 · Cited by 191
Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development
Waldner, M. J., & Neurath, M. F. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2013.12.003 · Cited by 198
STAT3 and apoptosis challenges in cancer
Fathi, N., Rashidi, G., Khodadadi, A., Shahi, S., & Sharifi, S. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.121 · Cited by 191
Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis
Mishra, J., Drummond, J., Quazi, S. H., Karanki, S. S., Shaw, J., Chen, B., & Kumar, N. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.09.014 · Cited by 184
Stat3 Is a Negative Regulator of Intestinal Tumor Progression in ApcMin Mice
Musteanu, M., Blaas, L., Mair, M., Schlederer, M., Bilban, M., Tauber, S., Esterbauer, H., Mueller, M., Casanova, E., Kenner, L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.11.049 · Cited by 168
Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030
Lü, L., Liu, Y., Li, H., Li, P., Fuchs, J. R., Shibata, H., Iwabuchi, Y., & Lin, J. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.200 · Cited by 164
Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs
Degagné, É., Pandurangan, A. K., Bandhuvula, P., Kumar, A., Eltanawy, A., Zhang, M., Yoshinaga, Y., Nefedov, M. D., de Jong, P. J., Fong, L. G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74188 · Cited by 157
Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade
Zhang, Z., Duan, Q., Zhao, H., Liu, T., Wu, H., Shen, Q., Wang, C., & Yin, T. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.08.023 · Cited by 153
The role of IL-21 in immunity and cancer
Davis, M. R., Zhu, Z., Hansen, D. M., Bai, Q., & Fang, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.12.047 · Cited by 153
A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells
Lin, L., Deangelis, S., Foust, E., Fuchs, J. R., Li, C., Li, P., Schwartz, E. B., Lesinski, G. B., Benson, D., Lü, J., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-217 · Cited by 152
Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling
Zhang, J.-F., He, M., Fu, W.-M., Wang, H., Chen, L., Zhu, X. M., Chen, Y., Xie, D., Lai, P. B. S., Chen, G., et al. (2010) · Hepatology · doi:10.1002/hep.24595 · Cited by 145
Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
Beebe, J., Liu, J., & Zhang, J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.006 · Cited by 144
The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy
Garg, M., Shanmugam, M. K., Bhardwaj, V., Goel, A., Gupta, R., Sharma, A., Baligar, P., Kumar, A. P., Goh, B. C., Wang, L., et al. (2020) · Medicinal Research Reviews · doi:10.1002/med.21761 · Cited by 143
Signal Transducer and Activator of Transcription 3 Activation Promotes Invasive Growth of Colon Carcinomas through Matrix Metal loproteinase Induction
Tsareva, S. A., Moriggl, R., Corvinus, F. M., Wiederanders, B., Schütz, A., Kovačic, B., & Friedrich, K. (2007) · Neoplasia · doi:10.1593/neo.06820 · Cited by 137
Self-citation
The many faces of Janus kinase
Seavey, M. M., & Dobrzański, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.024 · Cited by 136
The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis
Rosen, D. G., Mercado‐Uribe, I., Yang, G. S., Bast, R. C., Amin, H. M., Lai, R. L., & Liu, J. (2006) · Cancer · doi:10.1002/cncr.22293 · Cited by 133
MiR-9, -31, and -182 Deregulation Promote Proliferation and Tumor Cell Survival in Colon Cancer
Cekaite, L., Rantala, J., Bruun, J., Guriby, M., Ågesen, T. H., Danielsen, S. A., Lind, G. E., Nesbakken, A., Kallioniemi, O., Lothe, R. A., et al. (2012) · Neoplasia · doi:10.1593/neo.121094 · Cited by 133
The role of the interleukin (IL)-6/IL-6 receptor axis in cancer
Taher, M. Y., Davies, D. M., & Maher, J. F. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180136 · Cited by 138
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia
Eiring, A. M., Page, B. D. G., Kraft, I. L., Mason, C. C., Vellore, N. A., Resetca, D., Zabriskie, M. S., Zhang, T. Y., Khorashad, J. S., Engar, A., et al. (2014) · Leukemia · doi:10.1038/leu.2014.245 · Cited by 140
Self-citation
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo
Spitzner, M., Roesler, B., Bielfeld, C., Emons, G., Gaedcke, J., Wolff, H. A., Rave‐Fränk, M., Kramer, F., Beissbarth, T., Kitz, J., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28429 · Cited by 128
Early-onset colorectal cancer: A sporadic or inherited disease?
Stigliano, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i35.12420 · Cited by 129
IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer
Yao, C., Su, L., Shan, J., Zhu, C., Liu, L., Liu, C., Xu, Y., Yang, Z., Bian, X., Shao, J., et al. (2016) · Stem Cells · doi:10.1002/stem.2320 · Cited by 123
The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target
Shalaby, A., Presneau, N., Ye, H., Halai, D., Berisha, F., Idowu, B. D., Leithner, A., Liegl, B., Briggs, T. W. R., Bácsi, K., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2818 · Cited by 117
STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH+/CD133+ stem cell-like human colon cancer cells
Lin, L., Fuchs, J. R., Li, C., Olson, V., Bekaii‐Saab, T., & Lin, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.112 · Cited by 116
Augmented gp130‐mediated cytokine signalling accompanies human gastric cancer progression
Cb, J., Judd, L. M., Menheniott, T. R., Kronborg, I., Dow, C., Yeomans, N. D., Boussioutas, A., Robb, L. G., & Giraud, A. (2007) · The Journal of Pathology · doi:10.1002/path.2218 · Cited by 122
Targeting STAT3 Signaling Pathway in Colorectal Cancer
Gargalionis, A. N., Papavassiliou, K. A., & Papavassiliou, A. G. (2021) · Biomedicines · doi:10.3390/biomedicines9081016 · Cited by 115
The regulatory roles of phosphatases in cancer
Stebbing, J., Lit, L. C., Zhang, H., Darrington, R. S., Melaiu, O., Rudraraju, B., & Giamas, G. (2013) · Oncogene · doi:10.1038/onc.2013.80 · Cited by 113
The Interleukin-22/STAT3 Pathway Potentiates Expression of Inducible Nitric-oxide Synthase in Human Colon Carcinoma Cells
Ziesché, E., Bachmann, M., Kleinert, H., Pfeilschifter, J. M., & Mühl, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611040200 · Cited by 118
STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation
Laßmann, S., Schuster, I., Walch, A. K., Göbel, H., Jütting, U., Makowiec, F., Hopt, U. T., & Werner, M. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.035113 · Cited by 114
Molecular mechanisms in colitis-associated colorectal cancer
Zhou, R. W., Harpaz, N., Itzkowitz, S. H., & Parsons, R. E. (2023) · Oncogenesis · doi:10.1038/s41389-023-00492-0 · Cited by 123
Myeloid-Derived Suppressor Cells in Colorectal Cancer
Siemińska, I., & Baran, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01526 · Cited by 115
Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells
Silva, V. R., Santos, L. D. S., Dias, R. B., Quadros, C. A., & Bezerra, D. P. (2021) · 癌症：英文版 · doi:10.1002/cac2.12235 · Cited by 106
Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src-mediated phosphorylation of EGF receptor tyrosine kinase
Kundu, J., Choi, B. Y., Jeong, C., Kundu, J. K., & Chun, K. (2014) · Oncology Reports · doi:10.3892/or.2014.3223 · Cited by 106
ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer
Van Schaeybroeck, S., Kalimutho, M., Dunne, P. D., Carson, R., Allen, W., Jithesh, P. V., Redmond, K. L., Sasazuki, T., Shirasawa, S., Blayney, J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.032 · Cited by 106
Targeting STAT3 in cancer and autoimmune diseases
Gharibi, T., Babaloo, Z., Hosseini, A., Abdollahpour‐Alitappeh, M., Hashemi, V., Marofi, F., Nejati‐Koshki, K., & Baradaran, B. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173107 · Cited by 105
Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling
To, N. B., Nguyen, Y. T.-K., Moon, J. Y., Ediriweera, M. K., & Cho, S. K. (2020) · Nutrients · doi:10.3390/nu12061663 · Cited by 111
Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma
Gordziel, C., Bratsch, J., Moriggl, R., Knösel, T., & Friedrich, K. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.274 · Cited by 102
Self-citation
Recent development of transition metal complexes with in vivo antitumor activity
Liang, J., Zhong, H., Yang, G., Vellaisamy, K., Ma, D., & Leung, C. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.06.002 · Cited by 101
Effects of Helicobacter pylori infection on intestinal microbiota, immunity and colorectal cancer risk
Engelsberger, V., Gerhard, M., & Mejías‐Luque, R. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1339750 · Cited by 110
Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells
Han, S., Jeong, A. J., Yang, H., Kang, K. B., Lee, H., Yi, E. H., Kim, B., Cho, C., Chung, J. W., Sung, S. H., et al. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.08.039 · Cited by 98
Withaferin-A Inhibits Colon Cancer Cell Growth by Blocking STAT3 Transcriptional Activity
Choi, B. Y., & Kim, B.-W. (2015) · Journal of Cancer Prevention · doi:10.15430/jcp.2015.20.3.185 · Cited by 97
The role of signal transducers and activators of transcription in colon cancer
Klampfer, L. (2007) · Frontiers in bioscience · doi:10.2741/2893 · Cited by 97
Targeting STAT3 in gastric cancer
Giraud, A. S., Menheniott, T. R., & Judd, L. M. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.709238 · Cited by 93
Molecular markers and targets for colorectal cancer prevention
Janakiram, N. B., & Rao, C. V. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00742.x · Cited by 92
Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
Ye, T., Yang, F., Zhu, Y., Li, Y., Lei, Q., Song, X., Xia, Y., Xiong, Y., Zhang, L., Wang, N., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.452 · Cited by 92
Adiponectin blocks multiple signaling cascades associated with leptin‐induced cell proliferation in ApcMin/+ colon epithelial cells
Fenton, J. I., Birmingham, J., Hursting, S. D., & Hord, N. G. (2008) · International Journal of Cancer · doi:10.1002/ijc.23436 · Cited by 89
Direct Targeting Options for STAT3 and STAT5 in Cancer
Orlova, A., Wagner, C., de Araujo, E. D., Bajusz, D., Neubauer, H. A., Herling, M., Gunning, P. T., Keserű, G. M., & Moriggl, R. (2019) · Cancers · doi:10.3390/cancers11121930 · Cited by 88
Self-citation
Cytokine disbalance in common human cancers.
Culig, Z. (2011) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamcr.2010.12.010 · Cited by 98
Protein Tyrosine Signaling and its Potential Therapeutic Implications in Carcinogenesis
Kim, M., Baek, M., & Kim, D. J. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170616082125 · Cited by 92
Carnosol induces apoptosis through generation of ROS and inactivation of STAT3 signaling in human colon cancer HCT116 cells
PARK, K.-W., Kundu, J., Chae, I.-G., Kim, D.-H., Yu, M.-H., Kundu, J. K., & Chun, K. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2281 · Cited by 87
Unmasking the Many Faces of Tumor-Associated Neutrophils and Macrophages: Considerations for Targeting Innate Immune Cells in Cancer
Keeley, T. S., Costanzo-Garvey, D. L., & Cook, L. M. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.10.013 · Cited by 84
Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells
Tomida, M., Ohtake, H., Yokota, T., Kobayashi, Y., & Kurosumi, M. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0318-6 · Cited by 86
cGAS restricts colon cancer development by protecting intestinal barrier integrity
Hu, S., Fang, Y., Chen, X., Cheng, T., Zhao, M., Du, M., Li, T., Li, M., Zeng, Z., Wei, Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105747118 · Cited by 84
Cytokine Induction of Tumor Necrosis Factor Receptor 2 Is Mediated by STAT3 in Colon Cancer Cells
Hamilton, K. E., Simmons, J. G., Ding, S., Landeghem, L. V., & Lund, P. K. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0210 · Cited by 86
Correlation of β-Catenin Localization with Cyclooxygenase-2 Expression and CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer
Kawasaki, T., Nosho, K., Ohnishi, M., Suemoto, Y., Kirkner, G. J., Dehari, R., Meyerhardt, J. A., Fuchs, C. S., & Ogino, S. (2007) · Neoplasia · doi:10.1593/neo.07334 · Cited by 80
IRAK-M Expression in Tumor Cells Supports Colorectal Cancer Progression through Reduction of Antimicrobial Defense and Stabilization of STAT3
Kesselring, R., Gläsner, J., Hiergeist, A., Naschberger, E., Neumann, H., Brunner, S. M., Wege, A. K., Seebauer, C. T., Köhl, G., Merkl, S., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.014 · Cited by 84
Cryptotanshinone, a Stat3 inhibitor, suppresses colorectal cancer proliferation and growth in vitro
Li, W., Saud, S. M., Young, M. R., Colburn, N. H., & Hua, B. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2424-0 · Cited by 80
Carnosic acid inhibits STAT3 signaling and induces apoptosis through generation of ROS in human colon cancer HCT116 cells
Kim, D., Park, K., Chae, I. G., Kundu, J., Kim, E., Kundu, J. K., & Chun, K. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22353 · Cited by 79
JAK/STAT signalling pathway in colorectal cancer: A new biological target with therapeutic implications
Spano, J., Milano, G. A., Rixe, C., & Fagard, R. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.07.006 · Cited by 77
Synthesis and Anticancer Evaluation of New 1,3,4-Oxadiazole Derivatives
Stecoza, C. E., Nițulescu, G. M., Draghici, C. C., Căproiu, M. T., Olaru, O. T., Bostan, M., & Mihaila, M. A. (2021) · Pharmaceuticals · doi:10.3390/ph14050438 · Cited by 76
Inflammatory bowel disease and carcinogenesis
Nagao‐Kitamoto, H., Kitamoto, S., & Kamada, N. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10028-4 · Cited by 80
Inactivation of the vitamin D receptor in APCmin/+ mice reveals a critical role for the vitamin D receptor in intestinal tumor growth
Zheng, W., Wong, K. E., Zhang, Z., Dougherty, U., Mustafi, R., Kong, J., Deb, D. K., Zheng, H., Bissonnette, M., & Li, Y. C. (2011) · International Journal of Cancer · doi:10.1002/ijc.25992 · Cited by 75
CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression
Cui, H., Wang, S., Song, F., Cheng, X., Nan, G., Zhao, Y., Qian, M., Chen, X., Li, J., Liu, F.-L., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00677-2 · Cited by 74
CRH promotes human colon cancer cell proliferation via IL‐6/JAK2/STAT3 signaling pathway and VEGF‐induced tumor angiogenesis
Fang, X., Hong, Y., Dai, L., Qian, Y., Zhu, C., Wu, B., & Li, S. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22691 · Cited by 73
Colon cancer cells secrete exosomes to promote self-proliferation by shortening mitosis duration and activation of STAT3 in a hypoxic environment
Ren, R., Sun, H., Ma, C., Liu, J., & Wang, H. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0325-8 · Cited by 73
Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS 3
Singh, S., Chouhan, S., Mohammad, N., & Bhat, M. K. (2017) · FEBS Letters · doi:10.1002/1873-3468.12655 · Cited by 71
Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications
Xu, H., Liu, L., Li, W., Zou, D., Yu, J. Q., Wang, L., & Wong, C. C. (2020) · Oncogene · doi:10.1038/s41388-020-01587-3 · Cited by 70
Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
Gallo, G., Vescio, G., Paola, G. D., & Sammarco, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112295 · Cited by 72
STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells
Lin, L., Jou, D., Wang, Y., Ma, H., Liu, T., Fuchs, J. R., Li, P., Lü, J., Li, C., & Lin, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3728 · Cited by 72
Dietary cocoa inhibits colitis associated cancer: a crucial involvement of the IL-6/STAT3 pathway
Saadatdoust, Z., Pandurangan, A. K., Anandasadagopan, S. K., Esa, N. M., Ismail, A., & Mustafa, M. R. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.07.024 · Cited by 70

Authors: Corvinus, F. M., Orth, C., Moriggl, R., Tsareva, S. A., Wagner, S., Pfitzner, E. B., Baus, D., Kaufman, R., Huber, L. A., Zatloukal, K., Beug, H., Öhlschläger, P., Schütz, A., Halbhuber, K.-J., & Friedrich, K.
Affiliations: Friedrich Schiller University Jena (DE)
Research Institute of Molecular Pathology (AT)
Georg Speyer Haus (DE)
Universität Innsbruck (AT)
University of Graz (AT)
Leipzig University (DE)
Corresponding author: Friedrich, Karlheinz
ORCID: Moriggl, Richard
Pfitzner, Edith B.
Huber, Lukas A.
Zatloukal, Kurt
Venue: Neoplasia
Publisher: Elsevier BV
Published: 2005-06
Volume: 7
Issue: 6
Pages: 545-555
ISSN: 1476-5586 (ISSN-L)
DOI: 10.1593/neo.04571
PMC: PMC1501283
OpenAlex: W2014737409
Cited by: 427
References: 59
Citations by year: 2026: 9 · 2025: 15 · 2024: 27 · 2023: 21 · 2022: 28 · 2021: 40 · 2020: 29 · 2019: 22 · 2018: 15 · 2017: 27 · 2016: 24 · 2015: 30 · 2014: 24 · 2013: 30 · 2012: 17
FWCI: 4.53
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/3.0/ (vor, 3260 d)
Locations: Neoplasia (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by-nc-nd)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords: STAT3, colorectal cancer, constitutive STAT3 activation, interleukin-6, cell proliferation, tumor growth, tumor microenvironment, tumor xenografts, dominant-negative STAT3, therapeutic target, infiltrating lymphocytes
MeSH terms: Animals, Biopsy, Cell Differentiation, Colonic Neoplasms, DNA, Genes, Dominant, Humans, Immunohistochemistry, Lymphocytes, Mice, Nude, Neoplasm Transplantation, Retroviridae, Time Factors, Blotting, Western, Colorectal Neoplasms, Signal Transduction, Interleukin-6, Cell Line, Tumor, Cell Proliferation, STAT3 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Persistent STAT3 Activation in Colon Cancer Is Associated with Enhanced Cell Proliferation and Tumor Growth

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks